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ABSTRACT
Background
Proteomic analysis of amniotic fluid shows the presence of biomarkers characteristic of
intrauterine inflammation. We sought to validate prospectively the clinical utility of one such
proteomic profile, the Mass Restricted (MR) score.
Methods and Findings
We enrolled 169 consecutive women with singleton pregnancies admitted with preterm
labor or preterm premature rupture of membranes. All women had a clinically indicated
amniocentesis to rule out intra-amniotic infection. A proteomic fingerprint (MR score) was
generated from fresh samples of amniotic fluid using surface-enhanced laser desorption
ionization (SELDI) mass spectrometry. Presence or absence of the biomarkers of the MR score
was interpreted in relationship to the amniocentesis-to-delivery interval, placental inflamma-
tion, and early-onset neonatal sepsis for all neonates admitted to the Newborn Special Care
Unit (n ¼ 104). Women with ‘‘severe’’ amniotic fluid inflammation (MR score of 3 or 4) had
shorter amniocentesis-to-delivery intervals than women with ‘‘no’’ (MR score of 0)
inflammation or even ‘‘minimal’’ (MR score of 1 or 2) inflammation (median [range] MR 3–4:
0.4 d [0.0–49.6 d] versus MR 1–2: 3.8 d [0.0–151.2 d] versus MR 0: 17.0 d [0.1–94.3 d], p , 0.001).
Nonetheless, a ‘‘minimal’’ degree of inflammation was also associated with preterm birth
regardless of membrane status. There was a significant association between the MR score and
severity of histological chorioamnionitis (r ¼ 0.599, p , 0.001). Furthermore, neonatal
hematological indices and early-onset sepsis significantly correlated with the MR score even
after adjusting for gestational age at birth (OR for MR 3–4: 3.3 [95% CI, 1.1 to 9.2], p ¼ 0.03).
When compared with other laboratory tests routinely used to diagnose amniotic fluid
inflammation and infection, the MR score had the highest accuracy to detect inflammation
(white blood cell count . 100 cells/mm
3), whereas the combination of Gram stain and MR
score was best for rapid prediction of intra-amniotic infection (positive amniotic fluid culture).
Conclusions
High MR scores are associated with preterm delivery, histological chorioamnionitis, and early-
onset neonatal sepsis. In this study, proteomic analysis of amniotic fluid was shown to be the
most accurate test for diagnosis of intra-amniotic inflammation, whereas addition of the MR
score to the Gram stain provides the best combination of tests to rapidly predict infection.
The Editors’ Summary of this article follows the references.
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Preterm delivery remains a major public health problem
with lasting family and societal repercussions [1]. Prevention
strategies have failed, and the prevalence of preterm birth in
the United States rose to an unprecedented 12.3% in 2003 [2].
Preterm birth accounts for almost 70% of neonatal deaths
and up to 75% of neonatal morbidity [1]. The consequences
for the neonate can prove devastating when intra-amniotic
infection is superimposed upon prematurity [1].
Both clinically symptomatic and asymptomatic intrauter-
ine infection induce an intra-amniotic inﬂammatory re-
sponse that includes the release of multiple cytokines and
chemokines that in turn may trigger preterm contractions
and/or rupture of the membranes [3]. Whereas an adequate
innate and adaptive immune response is critical for survival
of mother and child [4], a robust intrauterine inﬂammation
remains a major risk for poor cognitive and neurodevelop-
mental outcome [5–7]. Thus, rapid and accurate recognition
of inﬂammation in utero is critical if targeted interventions
to change outcome are to be developed [8]. Unfortunately,
this pursuit is complicated by the absence of rapid, sensitive,
and speciﬁc diagnostic tests for intrauterine inﬂammation.
The science of proteomics has been applied to the search
for biomarkers and generation of protein proﬁles that can
rapidly aid the prediction, early diagnosis, and treatment of
human diseases [9–13]. We have shown previously that
proteomic mapping of amniotic ﬂuid (AF) reveals a proﬁle
characteristic of intra-amniotic inﬂammation [14]. The
sensitivity and speciﬁcity reached 100% in blinded testing
[14]. Yet, the original enthusiasm for the ‘‘omics’’ discoveries
was dampened by concern that these approaches are not truly
disease speciﬁc and reproducible [15].
In this study, we sought to determine in a prospective and
blinded fashion whether a previously identiﬁed proteomic
proﬁle comprised of four protein biomarkers (neutrophil
defensins-1 and 2 and calgranulins A and C) is reproducible
and maintains its highly accurate ‘‘signature’’ when compared
to previously established or proposed markers of intra-
amniotic ﬂuid inﬂammation or infection: glucose, white
blood cell (WBC) count, lactate dehydrogenase (LDH), Gram
stain, interleukin-6 (IL-6), and matrix metalloprotease-8
(MMP-8). We further tested whether proteomic analysis of
AF relates to pregnancy outcome, pathologic evaluation of
the placenta, and early-onset neonatal sepsis.
Methods
Study Population and Specimens
AF was retrieved by ultrasound-guided amniocentesis from
169 consecutive women with singleton pregnancy following
admission at Yale-New Haven Hospital with symptoms of
premature labor (PTL), advanced cervical dilatation, and/or
preterm premature rupture of membranes (PPROM). After
the procedure, each woman was followed prospectively up to
the point of delivery. The decision to recommend amnio-
centesis or delivery of the fetus was made by the primary
clinical provider, independent of the research protocol. The
Yale University Human Investigation Research Board ap-
proved the study (February 2004–April 2006). Written
informed consent was obtained from all participants. Gesta-
tional age (GA) was established based on an ultrasonographic
examination prior to 20 wk in all instances. Preterm labor was
deﬁned as regular uterine contractions associated with
advanced cervical dilatation or effacement less than 37-wk
gestation [16].
Membrane rupture was conﬁrmed either by direct visual-
ization of AF ‘‘pooling’’ on speculum examination, positive
‘‘nitrazine’’ and ‘‘ferning’’ tests, or by the infusion of indigo
carmine into the amniotic sac. In patients with PPROM,
cervical dilatation was interpreted based on visual inspection
of the cervix at the time of the sterile speculum exam.
Advanced cervical dilatation was deﬁned as cervical dilata-
tion of 3 cm or more. Clinical chorioamnionitis was
diagnosed in the presence of maternal fever (.37.8 8C),
uterine tenderness, foul-smelling AF or visualization of pus at
the time of the speculum exam, maternal tachycardia ( 100
beats/min), or fetal tachycardia ( 160 beats/min) [16].
Induction of labor or a surgical delivery was performed for
such clinical indications as a prolapsed umbilical cord or a
GA of 34 wk or more [17], or AF laboratory results (glucose,
LDH, WBC count, Gram stain, and microbial cultures)
traditionally considered to indicate intra-amniotic inﬂam-
mation/infection [16]. The decision for delivery was made by
the primary physician who was blinded to all research test
results.
In our prior descriptive study of the AF proteomic proﬁle
[14], intra-amniotic inﬂammation was deﬁned as an AF WBC
count greater than 100 cells/mm
3. To validate and test the
diagnostic performance of the proteomic proﬁle in a
prospective fashion, a similar deﬁnition of inﬂammation
was maintained.
AF was cultured for aerobic and anaerobic bacteria, and
Ureaplasma and Mycoplasma species. The clinical laboratory
performed the glucose and LDH measurements, the WBC and
red blood cell (RBC) counts, and the Gram staining. In four
women, the WBC count could not be reported due to marked
cellular destruction secondary to gross bacterial invasion of
the AF. The clinical laboratory results were available to the
primary care providers for clinical management.
A proteomic ﬁngerprint, the Mass Restricted (MR) score,
was immediately generated from the fresh AF using a single
surface-enhanced laser desorption ionization time-of-ﬂight
(SELDI-TOF) mass spectrometer instrument [14]. The MR
score provides qualitative information regarding the pres-
ence or absence of intra-amniotic inﬂammation [14]. The MR
score ranges from 0 to 4, depending upon the presence or
absence of each of the four protein biomarkers [14]. A
categorical value of 1 is assigned if a particular peak is
present and 0 if absent. A score of 3–4 indicates the presence
of inﬂammation, whereas a score of 0–2 excludes it [14].
However, in the current investigation, we also stratiﬁed the
study population based on the ‘‘severity’’ of inﬂammation
(MR ¼ 0 indicates ‘‘no’’ inﬂammation; MR ¼ 1–2 indicates
‘‘minimal’’ inﬂammation; and MR ¼ 3–4 indicates ‘‘severe’’
inﬂammation). One investigator (author IAB) performed all
the protein chip array readings and scored all the samples
‘‘blindly,’’ being unaware of either clinical presentation or
outcome. The MR score results were not used for clinical
management. The remaining AF was centrifuged at 3,000 g, 4
8C for 10 min., aliquoted for research purposes, and stored at
 80 8C until IL-6 and MMP-8 levels were measured using
speciﬁc enzyme-linked immunosorbent assays (ELISAs)
[18,19].
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The methodology for generation of the MR score was
previously described in detail [14,20]. The time necessary to
prepare and report the MR score was documented electroni-
cally for each AF sample. We also investigated the minimum
incubation time required to obtain an adequate SELDI
spectrum for a reliable diagnosis of inﬂammation. For this
purpose, eight AF samples from women with known MR
scores of 4 and positive AF microbial cultures were placed on
H4 ProteinChip arrays and incubated for 1 h as per general
protocol or for shorter times (15, 30, or 45 min) before
calculation of the MR scores.
AF glucose levels and total LDH activity were measured
using an autoanalyzer (Roche/Hitachi SWA ISE 1800, http://
www.roche-diagnostics.com). The lower limit of detection for
this instrument is 2 mg/dl (0.11 mmol/l) for glucose and 1 U/l
for the LDH. The coefﬁcient of variation is less than 1% for
glucose and less than 5% for the LDH. Because several AF
glucose cutoffs ( 15 mg/dl or  10 mg/dl) have been reported
in the literature to best predict intra-amniotic inﬂammation
and/or infection, we analyzed the performance of both [21].
LDH levels of 419 U/l or greater were considered clinically
suggestive of intra-amniotic inﬂammation and/or infection
[22].
ELISAs for human IL-6 (Pierce-Endogen, http://www.
piercenet.com) and MMP-8 (R & D Systems, http://www.
rndsystems.com) were performed in duplicate according to
the manufacturers’ instructions by investigators unaware of
the sample origin. The minimum detectable concentration
for IL-6 was 1 pg/ml and less than 0.02 ng/ml for MMP-8. The
inter- and intra-assay coefﬁcients of variation were less than
10% for IL-6 and less than 6% for MMP-8, respectively. An
AF concentration above 11.4 ng/ml for IL-6 and 23 ng/ml for
MMP-8 were considered indicative of intra-amniotic inﬂam-
mation or infection [18,19].
Histological Evaluation of the Placenta for Acute
Inflammation
At Yale New Haven Hospital, placental pathologic study is a
routine part of the evaluation of a pregnancy complicated by
PTL or PPROM. Because several patients enrolled in our
study delivered at term or outside our hospital following
discharge, tissue sections were available from only 117
patients who also provided AF samples. Sections were read
by a perinatal pathologist unaware of the results of the
proteomic proﬁling. From each placenta, sections of cho-
rionic plate, extraplacental membranes, and umbilical cord
were examined systematically for inﬂammation. Three
histological stages of chorioamnionitis [23] (stage I: inter-
villositis, stage II: chorionic inﬂammation, and stage III: full
thickness inﬂammation of both chorion and amnion) were
complemented by the histological grading system devised by
Salaﬁa et al. which includes four grades of inﬂammation of
the amnion, chorion-decidua, and umbilical cord [24].
Evaluation of Early-Onset Neonatal Sepsis
Neonatal hematological indices and sepsis categorization
were assessed as previously described [25,26] from blood
specimens and cultures obtained immediately following
delivery for all neonates admitted to the Newborn Special
Care Unit (n¼104) by an investigator (author VB) unaware of
the results of the proteomic proﬁling. All neonates under-
went clinical and laboratory evaluations of sepsis. Clinical
indications for early-onset neonatal sepsis included lethargy,
apnea, respiratory distress, hypoperfusion, and shock. Early-
onset neonatal sepsis was deﬁned as the presence of
conﬁrmed or suspected sepsis at less than 3 d after birth.
Conﬁrmed sepsis was established when either the blood and/
or cerebrospinal ﬂuid culture was positive. Suspected sepsis
was diagnosed in the presence of clinical suspicion of sepsis
with support from other laboratory results. Early-onset
neonatal sepsis was dichotomized into present (when sepsis
was either conﬁrmed or suspected) or absent, and coefﬁcients
of associations with other binary variables were calculated.
Laboratory criteria were based on modiﬁcation of the criteria
of Rodwell et al. [25] when two or more of the following were
observed: absolute neutrophil count (ANC) less than 7,500/ml
or greater than 14,500/ml, absolute band count (ABC) greater
than 1,500/ml, immature/total neutrophil ratio (I:T ratio)
geater than 0.16, platelet count less than 150,000 cells/mm
3,o r
an abnormal spinal tap [26]. All neonates with suspected or
conﬁrmed sepsis received antibiotic therapy.
Statistical Analysis
Statistical analyses were performed with Sigma Stat,
version 2.03 (SPSS, http://www.spss.com) and MedCalc (Med-
Calc Software, http://www.medcalc.be) statistical software. To
avoid introducing spectrum bias [27], no patient or AF
sample was excluded from the ﬁnal analysis; a search for
intra-amniotic inﬂammation/infection was made in each
sample and a clinical decision taken independently following
review of the laboratory results for each amniocentesis
procedure. Test accuracy (cases correctly classiﬁed divided
by total number of cases), sensitivity, speciﬁcity, positive and
negative predictive values (PPV and NPV, respectively) were
measured for each assay by examining the distribution of
individual AF tests on receiver operator characteristic (ROC)
plots. Because amniocenteses were performed across a wide
range of gestation periods, the times from the amniocentesis
to birth for the 169 patients were normalized to reﬂect
pregnancy prolongation after amniocentesis as previously
described [28]. The percent prolongation of pregnancy was
calculated by dividing the amniocentesis-to-delivery interval
by the number of days gestation at amniocentesis times 100.
Kaplan-Meier probability plots were generated based on the
duration from amniocentesis to delivery and their differences
tested with the log-rank test (GraphPad Software, http://www.
graphpad.com). Continuous data were compared with the
Student t-test and one-way analysis of variance (ANOVA)
followed by Student-Newman-Keuls tests (parametric) or
Kruskal-Wallis on ranks followed by the Dunn tests (non-
parametric) to adjust for multiple comparisons as appropri-
ate. Comparisons between proportions were done with the
Chi-square test or Chi-square test for trend (MedCalc). Two-
by-two contingency tables were constructed and Chi-square
analysis of independence was used to identify signiﬁcant
differences among test performances. The phi-coefﬁcient of
correlation (U), an index of association for binary data, was
also calculated [29]. Variables (glucose, LDH, gram stain, IL-6,
and MMP-8) were dichotomized based on the deﬁned clinical
thresholds. Multiple stepwise linear and logistic regression
analyses were used to adjust p-values and odds ratios (ORs),
respectively, for potential inﬂuences of gestational age or
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indicate signiﬁcance.
Results
Characteristics of Women and at the Time of Sampling
The clinical characteristics of the women at amniocentesis
are presented in Table 1. The median time from rupture to
amniocentesis in the PPROM group was 9 h (range: 0.5–745.5
h). However, the amniocentesis-to-delivery interval was
shorter for the PPROM in comparison to the intact group.
Biochemical and Proteomic Assessment of Intra-amniotic
Inflammation and Infection
Women with PPROM had lower AF glucose levels com-
pared to the intact group (Table 2). A higher percentage of
women with PPROM had increased WBC and RBC counts and
a higher prevalence of a positive microbial culture result. The
most common isolates were Ureaplasma urealyticum (17/44),
Streptococcus species (9/44), and Bacteroides species (5/44). Eleven
women with positive AF cultures (25%) grew multiple
microbes. Women with PPROM had elevated levels of MMP-
8. More women with PPROM had a positive MR score (three
or four biomarkers present).
Biomarker Combinations and MR Scores
The distribution of MR scores in the 169 AF samples was:
MR 0: n ¼ 50 (29.6%); MR 1: n ¼ 22 (13.0%); MR 2: n ¼ 44
(26.0%); MR 3: n ¼ 23 (13.6%); and MR 4: n ¼ 30 (17.8%). All
but two samples with an MR score of 1 reﬂected the presence
of defensin 2 (P1, Figure 1A). Both exceptions had a peak
corresponding to calgranulin A (P4). In most instances (41/44,
93.2%), an MR of 2 reﬂected the presence of defensin 1 (P2)
and defensin 2 (P1). In only three instances, defensin 2 was
accompanied by calgranulin A. In all but one case, an MR of 3
reﬂected the combination of defensins 1 and 2 and
calgranulin C (P3). This suggests a sequential appearance of
the biomarkers in women with intra-amniotic inﬂammation/
infection.
AF MR Scores, Severity of Inflammation, and Pregnancy
Outcome
We used Kaplan-Meier analysis to examine the relationship
between the severity of inﬂammation (MR score) and the
duration of the amniocentesis-to-delivery interval. Women
with ‘‘severe’’ inﬂammation (MR scores of 3 or 4) had shorter
amniocentesis-to-delivery intervals than women with ‘‘no’’
(MR scores of 0) inﬂammation, or ‘‘minimal’’ (MR scores of 1
or 2) inﬂammation (median [range] MR 3–4: 0.4 d [0.0–49.6 d]
versus MR 1–2: 3.8 d [0.0–151.2 d] versus MR 0: 17.0 d [0.1–
94.3 d], p , 0.001) (Figure 1B). Nineteen women had MR
scores of 3–4, but were all managed expectantly by the clinical
provider who was unaware of the results of proteomic
analysis. The median time from the amniocentesis to delivery
in this subgroup of women was 0.7 d [0.0–49.6 d], which was
not signiﬁcantly different from that of the subgroup of
women with MR 3–4 managed with indicated delivery (p ¼
0.73).
We further focused our analysis by stratifying it by
membrane status (PPROM versus intact membranes). There
was a signiﬁcant relationship between the MR score and the
amniocentesis-to-delivery interval in pregnancies compli-
cated by PPROM. Women with PPROM and ‘‘severe’’
inﬂammation had signiﬁcantly shorter amniocentesis-to-
delivery intervals compared with women with both ‘‘mini-
mal’’ inﬂammation and ‘‘no’’ inﬂammation (MR 3–4: 0.7 d
[0.0–10.0 d] versus MR 1–2: 1.8 d [0.1–38.6 d] versus MR 0: 2.8
d [0.4–62.2 d], p , 0.01). The percent prolongation of
pregnancy among the three groups was also shorter in
women with severe inﬂammation (MR 3–4: 0.3%; MR 1–2:
0.8%; and MR 0: 1.4%, p ¼ 0.038). Women with intact
membranes had a longer pregnancy duration in the absence
of inﬂammation relative to the women with ‘‘severe’’ or
Table 1. Characteristics of Women (n¼169) Who Had a Clinically Indicated Amniocentesis to Rule Out Inflammation and Infection, and
Characteristics of Their Infants at Birth
Category Variable All Patients (n ¼ 169) PPROM (n ¼ 70) Intact (n ¼ 99) p-Value
Clinical characteristics
at amniocentesis
Gestational age at recruitment (wk), median (range) 28.2 (17.0–36.1) 29.8 (20.1–34.3) 26.2 (17.1–36.1) ,0.001
a
Age (y), median (range) 28 (16–46) 29 (16  46) 25 (17–40) 0.02
b
Gravidity, median (range) 2 (1–9) 2 (1–9) 2 (1–9) 0.96
a
Parity, median (range) 1 (0–6) 1 (0–5) 0 (0–6) 0.01
a
History of PTD, n (%) 40 (23.6) 15 (21.4) 25 (25.3) 0.69
c
Cervical dilatation (cm), median (range) 1 (0–10) 0 (0–5) 1.5 (0–10) ,0.001
a
Uterine contractions, n (%) 72 (43.0) 18 (25.7) 54 (54.5) ,0.001
c
Clinical chorioamnionitis, n (%) 18 (10.6) 8 (14.4) 10 (10.1) 0.82
c
Advanced cervical dilatation ( 3c m ) ,n (%) 47 (27.8) 12 (17.1) 33 (33.3) 0.03
c
Outcome and
delivery measures
Gestational age at delivery (wk), median (range) 30.6 (17.0–40.4) 31.2 (20.4–35.1) 30.3 (17.0–40.4) 0.64
a
Amniocentesis–delivery interval (d), median (range) 2.8 (0.0–151.2) 1.4 (0.0–62.2) 7.1 (0.0–151.2) ,0.001
a
Apgar 1 min, median (range) 7 (0–9) 7 (0–9) 7 (0–9) 0.61
a
Apgar 5 min, median (range) 9 (0–9) 9 (0–9) 9 (0–9) 0.83
a
Birthweight (g), median (range) 1675 (160–4,160) 1630 (320–2,864) 1732 (160–4,160) 0.12
a
Cesarean delivery, n (%) 60 (35.5) 28 (40.1) 32 (32.3) 0. 38
c
aMann-Whitney test.
bStudent t-test.
cChi-square test.
doi:10.1371/journal.pmed.0040018.t001
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d] versus MR 1–2: 5 d [0.0–151.2 d] versus MR 0: 35.2 d [0.1–
94.3 d], p , 0.001). Women with intact membranes who had
‘‘minimal’’ inﬂammation had signiﬁcantly shorter pregnan-
cies compared to those with ‘‘no’’ inﬂammation (p ¼ 0.01).
The percent prolongation among these three groups declined
stepwise (MR 0: 15.1%; MR 1–2: 3.1%; and MR 3–4: 0.2%, p ,
0.001).
Relationships between Histological Evaluation of the
Placenta for Acute Inflammation and the MR Score
We further determined that the presence and the severity
of acute inﬂammation in the chorionic plate, amnion, chorio-
decidua, and umbilical cord were signiﬁcantly associated with
the occurrence and the degree of intra-amniotic inﬂamma-
tion as determined by the MR score (Table 3). The MR score
correlated signiﬁcantly with the stages of chorioamnionitis (r
¼ 0.599, p , 0.001). In multivariate regression analysis, both
the MR score and the amniocentesis-to-delivery interval
signiﬁcantly predicted severity of chorio-amnionitis (r ¼
0.617, MR score: p , 0.001; amniocentesis-to-delivery
interval: p ¼ 0.04).
Relationships between MR Score and Early-Onset
Neonatal Sepsis
Details on the neonate study population and hematological
indices are given in Table 4. Four neonates had conﬁrmed
sepsis documented through a positive blood culture. Neo-
nates delivered from mothers with AF MR 3–4 had
signiﬁcantly higher ABC (p , 0.001) and I:T ratio (p ,
0.001), and increased incidence of suspected and/or con-
ﬁrmed sepsis (OR: 4.4 [95% conﬁdence interval (CI), 1.7 to
11.6], p¼0.003) compared to neonates from mothers with MR
0 or MR 1–2 even after adjusting for GA at birth (ABC: p ¼
0.002; I:T ratio: p¼0.003). Suspected and conﬁrmed sepsis in
the neonatal period were associated signiﬁcantly with an MR
3–4 (Chi-square ¼ 8.270, U ¼ 0.305, p ¼ 0.004). The MR score
maintained this association when adjusted for GA at birth
(OR for MR 3–4: 3.3 [95% CI, 1.1 to 9.2], p ¼ 0.03 and for GA
at birth: 0.9 [95% CI, 0.8 to 1.0], p ¼ 0.15). In multivariate
logistical regression analysis with neonatal sepsis as a
dependent variable and a panel of clinical (amniocentesis-
to-delivery interval, clinical chorioamnionitis, GA at delivery,
and PPROM) or AF biochemical characteristics as independ-
ent variables, the MR score, but not the WBC count, was the
only variable with signiﬁcant predictive value (MR 3–4: p ¼
0.03, WBC count: p ¼ 0.48)
Performance of the MR Score and Other Rapid Markers in
Identification of Intra-amniotic Inflammation and Infection
Table 5 shows the estimates of the sensitivity, speciﬁcity,
positive and negative predictive values, and accuracy of each
method for the identiﬁcation of women with intra-amniotic
inﬂammation. The accuracy of an MR score of 3–4 was the
highest (92.6%), followed by LDH and glucose (cutoff   10
mg/dl). An MR score of 3–4 had the strongest association with
inﬂammation (Chi-square ¼ 105.3, U ¼ 0.822, p , 0.001),
followed by LDH (Chi-square ¼ 71.5, U ¼ 0.754, p , 0.001).
The MR score was originally designed to predict intra-
amniotic inﬂammation (WBC . 100 cells/mm
3) [14], but not
to determine the number of WBCs that must be present for
the MR score to change from a negative to a positive score.
Using ROC analysis, we now ﬁnd that a WBC cutoff of greater
than 38 cells/mm
3 predicts an MR score of 3–4. Thus, the MR
score is actually more precise for the identiﬁcation of intra-
amniotic inﬂammation compared to the recommended WBC
cutoffs. [16]. We next tested the utility of each test to predict
a positive AF culture result (Table 6). The Gram stain had the
highest speciﬁcity and accuracy for prediction of a positive
AF culture. The MR score was less predictive of infection,
consistent with its original design to assess inﬂammation. [14].
Table 2. Results of the AF Clinical Laboratory Tests, ELISA for the IL-6 and MMP-8 Levels, and Proteomics Analysis in Our Study
Population
Category Variable All Patients (n ¼ 169) PPROM (n ¼ 70) Intact (n ¼ 99) p-Value
Clinical laboratory tests Glucose (mg/dl), median (range) 24.5 (2–98) 18 (2–98) 29 (2–76) 0.03
a
Glucose , 15 mg/dl, n (%) 51 (30.2) 29 (41.4) 22 (22.2) 0.01
b
Glucose , 10 mg/dl, n (%) 36 (21.3) 19 (27.1) 17 (17.2) 0.20
b
WBC (cells/mm
3), median (range) 10 (0–132,000) 42 (1–132,000) 5 (0–2,320) ,0.001
c
WBC . 50 cells/mm
3, n (%) 52 (31.5) 31 (45.6) 21 (21.6) 0.001
b
WBC . 100 cells/mm
3, n (%) 43 (26.1) 27 (39.7) 16 (16.5) 0.001
b
RBC (cells/mm
3), median (range) 102 (0–672,000) 381.5 (0–672,000) 44 (0–58,800) ,0.001
c
LDH (U/l), median (range) 197 (52–4,560) 223.5 (56–4,560) 174 (52–3,630) 0.12
c
Positive Gram stain, n (%) 28 (16.5) 16 (22.8) 12 (2.1) 0.10
b
Positive amniotic fluid cultures, n (%) 44 (26.3) 28 (40.0) 16 (16.2) ,0.001
b
Immunoassays IL-6 ng/ml, median (range) 1.3 (0.02–129.6) 1.6 (0.02–100.3) 0.9 (0.02–129.6) 0.09
c
IL-6 . 11.4 ng/ml, n (%) 27 (15.9) 15 (21.4) 12 (12.1) 0.16
b
MMP-8 ng/ml, median (range) 20.2 (0.87–12,645) 41.5 (0.87–12,645) 14.8 (2.21–2,607) 0.001
c
MMP-8 . 23 ng/ml, n, (%) 80 (48.5) 39 (55.7) 43 (43.4) 0.12
b
Proteomics analysis MR score 3–4
d, n (%) 53 (31.4) 31 (44.2) 22 (22.2) 0.004
b
aStudent t-test.
bChi-square test.
cMann-Whitney test.
dMR score 3–4 was representative for ‘‘severe’’ inflammation.
doi:10.1371/journal.pmed.0040018.t002
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Inflammation and Infection
Results from the ﬁve laboratory tests (glucose, Gram stain,
LDH, IL-6, and MMP-8) were concordant in excluding
inﬂammation in 64.7% of cases. In contrast, the MR score
alone correctly excluded inﬂammation in 92.4% (p , 0.001)
of cases. When inﬂammation was present, the ﬁve tests were
concordantly positive in only 20.9%, whereas the MR score
conﬁrmed inﬂammation in 93.0% (p , 0.001).
We used stepwise logistic regression analysis to identify
which clinical test or combination of tests optimally
predicted inﬂammation, and found that the MR score
performed better than any test or combination of tests (OR:
136.0 [95% CI, 42.0 to 632.3], p , 0.0001), followed by LDH
(OR: 70.6 [95% CI, 20.7 to 240.7], p , 0.0001). We then asked
whether addition of any other tests to the MR score could add
signiﬁcantly to its predictive value. When all covariates were
entered into the model, only the MR score and LDH had a
signiﬁcant relationship with intra-amniotic inﬂammation
(MR score 3–4: OR: 32.6 [95% CI, 6.5 to 164.1], p , 0.001;
and LDH   419U/l: OR: 8.0 [95% CI, 1.7 to 38.6], p ¼ 0.009).
The addition of either IL-6 or MMP-8 to the model failed to
improve the prediction of inﬂammation.
Stepwise logistic regression analysis for prediction of a
positive AF culture revealed that the combination of Gram
stain and MR score was identiﬁed as best in predicting a
positive AF culture result (Gram stain: OR¼43.9 [95% CI, 9.6
to 200.5], and MR score: OR ¼ 19.6 [95% CI, 6.5 to 59.0], p ,
0.001). All the other covariates were excluded from the model
based on the signiﬁcance level p . 0.1. Addition of IL-6 and
MMP-8 to the model did not improve the prediction value of
an AF culture result.
When clinical variables such as maternal age, gravidity,
parity, GA at amniocentesis, history of prior preterm
delivery, cervical dilatation, and presence of uterine con-
tractions or clinical chorioamnionitis were also introduced
into the logistic regression model, none had signiﬁcant or
additive value for prediction of either infection or inﬂam-
mation.
Relationships between MR Score and Other Markers of AF
Inflammation and Infection
Because AF inﬂammation is thought to be an important
risk factor for neonatal morbidity and mortality, we tested
the relationships between the AF MR score, the WBC count,
IL-6 and MMP-8 levels, and glucose concentration in order to
conﬁrm our premise that MR scores of 1 and 2 reﬂect a lesser
degree of inﬂammation, whereas an MR score of 3–4 indicates
a more severe inﬂammation.
We found that women with MR 3–4 had higher (1) numbers
of WBCs (median [range] (Figure 2A): MR 0: 3 [0–200] versus
MR 1–2: 6 [0–767] versus MR 3–4: 532 [2–132,000] cells/mm
3, p
, 0.001); (2) levels of IL-6 (Figure 2B): (MR 0: 0.2 [0.0–5.1]
versus MR 1–2: 1.1 [0.0–86.3] versus MR 3–4: 11.1 [0.2–129.6]
ng/ml, p , 0.001); and (3) levels of MMP-8 (Figure 2C): (MR 0:
3.8 [0.9–82.0] versus MR 1–2: 17.7 [2.0–215.7] versus MR 3–4:
317.5 [4.0–12,644.58] ng/ml, p , 0.001). Amniotic ﬂuid glucose
concentration was lower in women with MR 3–4 (Figure 2D):
(MR 0: 33 [6–98] versus MR 1–2: 28 [6–61] versus MR 3–4: 6 [2–
56] mg/dl, p , 0.001). Because all the traditional tests for the
detection of intra-amniotic inﬂammation/infection are char-
acterized by a large variance, these ﬁndings indicate that only
the MR score can be used to precisely identify the degree of
inﬂammation present.
Figure 1. Proteomic Profiling of AF and Risk for Preterm Delivery
(A) Representative SELDI-TOF mass spectrometry profiles of the AF based on the ‘‘severity’’ of inflammation (MR¼0 indicates ‘‘no’’ inflammation; MR¼
2 indicates ‘‘minimal’’ inflammation; and MR ¼ 3–4 indicates ‘‘severe’’ inflammation). Five microliters of diluted AF (1:10) was placed in duplicate on
spots of H4 ProteinChip arrays (Ciphergen Biosystems, Fremont, California, United States) and incubated for 1 h. After 1 h, the AF samples were
aspirated, and the spots were individually washed three times with 25% acetonitrile solution, air dried, and then overlaid with matrix solution (1 llo f
20% saturated solution of a-cyano-4 hydroxycinnamic acid [CHCA] on one array and two overlays of 1 ll of 50% saturated solution of sinnapinic acid
[SPA] on the other array). The chips were air dried and then read in a Protein Biology System IIC (PBS IIC) SELDI-TOF mass spectrometer (Ciphergen
Biosystems) using the ProteinChip software v3.1.1. The CHCA chip allows for the identification of defensins 2 (P1: 3,377.01 Da) and 1 (P2: 3,448.09 Da).
The SPA chip allows for identification of the peaks corresponding to calgranulin C (P3: 10,443.85 Da) and calgranulin A (P4: 10,834.51 Da). The x-axis of
the tracings represents the molecular mass in Daltons; the y-axis represents the relative peak intensity.
(B) Cumulative probability of pregnancy maintenance for the 169 patients illustrating the duration from amniocentesis to delivery in women with MR
scores of 0 (zero), MR scores of 1–2, and MR scores 3–4.
doi:10.1371/journal.pmed.0040018.g001
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Proteomic Results
The median time required to perform and report the ﬁnal
results for glucose and LDH levels was 48 min (range: 21–353)
and 6.9 d (range: 2.1–24.4) for the AF cultures. The median
time required to process, read, and score each AF sample per
original protocol of the MR score [14] was 105 min (range:
65–161). However, in the current study, we determined that
the minimum time of incubation required to obtain an
accurate spectrum for defensin and calgranulin biomarkers
was 15 min.
Discussion
The results of this study indicate that proteomic proﬁling
of the amniotic ﬂuid is an accurate method for diagnosis of
clinically relevant intra-amniotic inﬂammation. High MR
scores are associated with preterm delivery, histological
chorioamnionitis, and early-onset neonatal sepsis. Our
research was motivated by the fact that validity from chance
and bias may cause erroneous results and inﬂate expectations
in observational proteomic research. To address such
potential bias and to make the scientiﬁc community aware
of the potential of new technology, it was critical that we
design, conduct, and provide interpretation of our proteomic
proﬁling in a totally unrelated population compared to the
original study and in fresh samples of AF [14].
Clinical diagnosis of chorioamnionitis is an insensitive
measure of the presence of inﬂammation, infection, or fetal
sepsis [30,31]. Although to date, amniocentesis to investigate
PTL or PPROM has not been demonstrated to have been of
any clinical beneﬁt in terms of the outcome, direct analysis of
the AF remains the most accurate and direct method to assess
for the presence or absence of intra-amniotic inﬂammation
and infection. We found that proteomic proﬁling of the AF
has the desired test characteristics for the detection of intra-
Table 3. Prevalence and Distribution of Stages and Grades of Acute Inflammation in the Chorionic Plate, Amnion, Chorio-decidua, and
Umbilical Cord Based on the ‘‘Severity’’ of Intra-amniotic Fluid Inflammation (n ¼ 117)
Location Histological Acute Inflammation MR ¼ 0( n ¼ 27) MR ¼ 1–2 (n ¼ 47) MR ¼ 3–4 (n ¼ 43) p-Value
Chorionic plate Stages [23], median (range) 0 (0–1) 1 (0–3) 3 (0–3) ,0.001
a
Stages II or III, n (%) 0 (0) 18 (38.3) 38 (88.3) ,0.001
b
Amnion Grades [24] , median (range) 0 (0–3) 0 (0–3) 3 (0–4) ,0.001
a
Grades 2–4, n (%) 3 (11.1) 14 (29.8) 34 (79.1) ,0.001
b
Chorio-decidua Grades, median (range) 0 (0–4) 2 (0–4) 3 (0–4) ,0.001
a
Grades 2–4, n (%) 10 (37.3) 26 (55.3) 42 (97.7) ,0.001
b
Umbilical cord Grades, median (range) 0 (0–4) 0 (0–4) 3 (0–4) ,0.001
a
Grades 1–4, n (%) 5 (18.5) 13 (27.7) 31 (72.1) ,0.001
b
aKruskal-Wallis ANOVA.
bChi-square test for trend.
MR ¼ 0 indicates ‘‘no’’ inflammation; MR ¼ 2 indicates ‘‘minimal’’ inflammation; and MR ¼ 3–4 indicates ‘‘severe’’ inflammation.
doi:10.1371/journal.pmed.0040018.t003
Table 4. Characteristics and Hematological Indices of Neonates Admitted to the Newborn Special Care Unit (n ¼ 104)
Category Variable MR ¼ 0( n ¼ 27) MR ¼ 1–2 (n ¼ 47) MR ¼ 3–4 (n ¼ 43) p–Value
Demographic and
birth characteristics
Gestational age at birth (wk), median (range) 33.2 (24.2–38.4) 30.6 (23.3–34.3) 27.6 (23.5–32.6) ,0.001
a
Birthweight (g), median (range) 2,078 (710–2,795) 1,555 (570–2,815) 1,110 (536–2,864) ,0.001
Apgar 1 min, median (range) 7 (1–9) 7 (0–9) 6 (0–9) 0.29
a
Apgar 5 min, median (range) 9 (6–9) 9 (1–9) 8 (1–9) 0.15
a
Analysis of
first CBC
Hemoglobin (g/dl), median (range) 15.8 (12.3–20.2) 15.0 (10.7–20.6) 14.2 (10.0–19.2) 0.06
Hematocrit (%), median (range) 48.4 (36.6–64.6) 47.3 (32.2–65.0) 44.2 (32.6–59.6) 0.17
WBC count (cells 3 1000 /mm
3), median (range) 10.0 (5.7–20.7) 10.7 (2.0–23.8) 11.9 (3.5–72.2) 0.27
a
Platelet count (cells 3 1,000/mm
3), median (range) 266 (197–435) 239 (56–487) 269 (128–490) 0.38
Differential
WBC count
Segmented (%), median (range) 30.5 (8.0–60.0) 32.0 (3.0–70.0) 33.5 (2.0–64.0) 0.68
Bands (%), median (range) 3.5 (0.0–21.0) 2.0 (0.0–21.0) 7.5 (0.0–39.0) ,0.001
a
Lymphocytes (%), median (range) 47.5 (14.0–85.0) 49.0 (13.0–82.0) 32.0 (4.0–84.0) ,0.001
Hematological
indices
ANC (cells/mm
3), median (range) 2,938 (456–9,315) 3,317 (60–12,950) 4,030 (100–43,320) 0.32
a
ABC (cells/mm
3), median (range) 425 (0–4,074) 260 (0–2,560) 872 (0–12,274) ,0.001
a
I:T ratio (%), median (range) 3.5 (0–21) 2.0 (0.0–21.0) 7.5 (0.0–36.0) ,0.001
a
Sepsis, n (%) 3 (11.5) 5 (13.5) 16 (39.0) 0.01
b
aOne way ANOVA; Kruskal-Wallis ANOVA.
bOne way ANOVA; Chi-square test.
doi:10.1371/journal.pmed.0040018.t004
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rily to infection [28]. Contrary to our initial investigation, we
found that the interpretation of the MR score in the real
world is not binary (‘‘disease present’’ or ‘‘disease absent’’),
rather it is a gradient progressing from the absence of disease
to ‘‘minimal’’ and then to ‘‘severe’’ inﬂammation. We
demonstrated that the WBC count (one of the tests used for
diagnosis of intra-amniotic inﬂammation) fails to effectively
separate groups by their risk of preterm birth until the WBC
level is very high. One does not need to be an obstetrician to
understand how difﬁcult it is in our current practice to
interpret the results of the clinical tests routinely ordered to
rule out infection and inﬂammation. Not only are the results
often discordant, but their subjective interpretation based on
previously reported diagnostic cutoffs for intra-amniotic
inﬂammation frequently leads to iatrogenic preterm delivery
in the absence of relevant conﬁrmatory information [20].
Our concordance analysis clearly demonstrates the supe-
riority and ease of interpretation of the MR score in
comparison with any other clinical test judged alone or as a
group. Proteomic proﬁling alone was able to correctly
conﬁrm or exclude inﬂammation in over 90% of our samples,
whereas the other ﬁve tests taken together performed much
less accurately. For clinical relevance, we compared the
diagnostic performance of the MR score against glucose,
WBC count, LDH, IL-6, and MMP-8 by using the clinical
laboratory cutoffs previously reported in the literature
[18,19,21,22]. Due to the retrospective nature of most of the
previous reports, further studies need to be done to re-
evaluate prospectively the cutoffs currently used by the
clinicians to best diagnose intra-amniotic inﬂammation and
infection, histological chorioamnionitis, and early-onset neo-
natal sepsis. Furthermore, such new cutoffs should be
compared in a prospective fashion against the MR score.
We further demonstrated that, whereas Gram stain has the
highest accuracy for the prediction of a positive AF culture,
the MR score is additive and their combination predicts
intra-amniotic infection long before the microbiological
results are reported to the clinician. It should not be
surprising that the MR score alone did not perform as well
for the prediction of a positive culture, because it was
designed to predict intra-amniotic inﬂammation [14], and
there are causes of inﬂammation other than infection (e.g.,
decidual hemorrhage and immunologic diseases) [28].
Lastly, there was a signiﬁcant association between a high
MR score, placental acute histological inﬂammation, and
both a shorter gestation and early-onset newborn sepsis. Our
ﬁnding that the MR score, but not the absolute AF WBC
count, is signiﬁcantly related with early-onset neonatal sepsis,
is provocative, and argues in support of the clinical utility of
proteomic proﬁling.
From a pathophysiological perspective, the biomarkers
comprising the MR score (defensins and calgranulins) are
bioactive antimicrobial and anti-inﬂammatory proteins re-
leased following neutrophil activation [32,33]. We found that
the components of a given MR score are not random, but
Table 6. Performances of Laboratory Tests in Identifying a Positive Amniotic Fluid Culture (n ¼ 169)
Amniotic Fluid Test Cutoff Sensitivity (95% CI) Specificity (95% CI) þPV  PV Accuracy (%)
MR score 3–4
a 79.5 (68.4–87.8) 85.6 (81.7–88.5) 66.0 92.2 84.0
Glucose  10 mg/dl 56.8 (45.8–65.7) 91.1 (87.2–94.3) 69.4 85.6 82.1
 15 mg/dl 70.5 (58.5–80.3) 80.6 (76.4–84.1) 56.4 88.5 78.0
WBC .100 cells/mm
3 67.5 (55.2–77.6) 86.9 (82.9–90.2) 62.8 89.1 82.1
LDH  419 U/l 60.6 (47.1–71.8) 88.5 (84.2–92.0) 62.5 87.6 81.8
Gram stain Positive 56.8 (47.8–61.2) 97.6 (94.4–99.1) 89.3 86.5 87.0
IL-6 .11.4 ng/dl 45.2 (36.6–52.9) 61.9 (44.7–77.3) 70.4 36.1 50.8
MMP-8 .23.0 ng/dl 90.7 (79.9–96.2) 65.0 (61.3–67.0) 47.6 95.2 71.7
aCutoff value corresponding to the highest accuracy (minimal false negative and false positive results).
 PV, negative predictive value; þPV, positive predictive value.
doi:10.1371/journal.pmed.0040018.t006
Table 5. Performances of Laboratory Tests in Identifying Intra-amniotic Inflammation (n ¼ 165)
Amniotic Fluid Test CutOff Sensitivity (95% CI) Specificity (95% CI) þPV  PV Accuracy (%)
MR score 3–4
a 93.0 (84.1–97.4) 92.4 (89.2–94.0) 81.6 97.3 92.6
Glucose  10 mg/dl 60.5 (49.8–68.4) 93.2 (89.3–96.1) 76.5 86.6 84.5
 15 mg/dl 76.7 (65.2–85.6) 83.9 (79.7–87.1) 63.5 90.8 82.0
LDH  419 U/l 78.8 (67.2–86.1) 95.0 (91.2–97.4) 83.9 93.1 91.0
Gram stain Positive 34.9 (24.9–43.3) 92.4 (88.8–95.5) 62.5 79.7 77.2
IL-6 .11.4 ng/dl 45.0 (34.5–52.4) 94.8 (91.2–97.4) 75.0 83.3 82.1
MMP-8 .23.0 ng/dl 92.9 (82.5–97.5) 66.7 (62.9–68.3) 50.0 96.3 73.6
Intra-amniotic Inflammation is defined as WBC count greater than 100 cells/mm
3. In four patients, WBC counts were not reported due to massive cellular destruction by bacteria.
aCutoff value corresponding to the highest accuracy (minimal false negative and false positive results).
 PV, negative predictive value; þPV, positive predictive value.
doi:10.1371/journal.pmed.0040018.t005
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initial phase of the intra-amniotic inﬂammatory response is
characterized by the appearance of defensins. Recognizing
that the neutrophil count does not necessarily reﬂect func-
tional responsiveness [34] and that neutrophil activation is a
complex sequential event, it is reasonable to suggest that the
generation of a proteomic ﬁngerprint like the MR score
provides a unique tool to monitor the degree of activation.
The median WBC count for the group of women with
‘‘minimal’’ inﬂammation (an MR score of 1 or 2) was
extremely low (six cells/mm
3). Currently, no clinical inter-
vention can be recommended based on such a low WBC
count. This argues for the clinical utility of performing
proteomic analysis and not an AF WBC count. In addition,
the results of our study seem to suggest that the MR score
(one to two biomarkers present) can identify women at risk of
premature delivery, when no clinical test other than
proteomic proﬁling can do it. Thus, it is critical that at this
stage, in women with ‘‘minimal’’ inﬂammation, we initiate as
soon as possible prospective randomized trials to determine
whether drugs with well-recognized anti-inﬂammatory prop-
erties (i.e., N-acetylcysteine) can halt the progress of diseases
and prolong pregnancy [8]. Furthermore, several women with
‘‘severe’’ inﬂammation (an MR score 3–4) showed a full
inﬂammatory response even when WBC counts were well
below the currently recommended cutoffs for inﬂammation.
This observation suggests that the concept of maternal and
fetal inﬂammation needs revision, because the degree of
neutrophil activation as reﬂected by the MR score may be
more clinically relevant than the absolute WBC count.
Because early-onset sepsis is a risk factor for neonatal
mortality and long-term neurodevelopmental outcome [1],
recent advances in proteomics open opportunities for early
recognition and treatment of the appropriate candidates [35].
In support of the proteomic proﬁle, early-onset neonatal
sepsis was associated signiﬁcantly with an MR 3–4, but not
with the AF WBC count. Certainly the ﬁndings of the current
study are stimulating and set the stage for prospective
randomized studies to determine the need, the duration of
the antibiotic exposure of the newborn following delivery,
and the long-term neurological outcome of the infant
according to their AF MR score and or the treatment of
choice made on the basis of the MR score.
One of the strengths of the present study in comparison
with other studies is the inclusion of all amniocentesis
samples in a prospective fashion rather than a predetermined
selection of biological samples from diverse tissue banks. We
also recognize the limitations of the investigation, as there is
no antenatal clinical test that can be viewed as the gold
standard for diagnosis of inﬂammation, and performance of a
concurrent placental biopsy in utero to establish histological
inﬂammation at the time of AF sampling is not possible.
D e s p i t et h i s ,o u rd a t ai n d i c a t et h a tt h ep r e s e n c eo f
biomarkers characteristic of intra-amniotic inﬂammation is
related to the presence and the degree of acute histological
inﬂammation at delivery. This again argues in support of the
Figure 2. Proteomic Profiling of AF Versus Results of Other Diagnostic Tests of Intra-amniotic Inflammation and/or Infection
(A) AF median WBC count, (B) ELISA for the IL-6 (C) and MMP-8 levels, and (D) glucose concentration in the same samples of AF (n¼169) varied with the
degree of inflammation. Several degrees of inflammation were established using SELDI-TOF mass spectrometry (MR ¼ 0 indicates ‘‘no’’ inflammation;
MR¼2 indicates ‘‘minimal’’ inflammation; and MR¼3–4 indicates ‘‘severe’’ inflammation). Statistical comparisons were performed using Kruskal-Wallis
ANOVA.
doi:10.1371/journal.pmed.0040018.g002
PLoS Medicine | www.plosmedicine.org January 2007 | Volume 4 | Issue 1 | e18 0092
Clinical Proteomics of Amniotic Fluidhigh accuracy of the MR scoring in detecting intra-amniotic
inﬂammation as reﬂected by the AF WBC count, but also by
the pathologic evaluation of the placenta.
In summary, in this study proteomic proﬁling of the AF was
shown to be the most accurate test to identify women with
intra-amniotic inﬂammation and assess the degree of
neutrophil activation in the setting of preterm labor.
Abnormal MR scores are associated with histological cho-
rioamnionitis and early-onset neonatal sepsis.
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Background. A preterm delivery, or premature birth, is normally defined
as one that occurs before 37 weeks after the last menstrual cycle (an
average pregnancy lasts around 40 weeks). Premature birth is fairly
common, with around 12% of births in the US fitting this definition.
However, it has serious consequences, being responsible for around 70%
of infant deaths and other adverse outcomes for the baby. It is not clear
in all cases what directly causes premature birth or how to identify cases
in which mother and child are at greater risk of serious outcomes.
Evidence from case-control and other studies strongly suggests that
infections of the uterus, placenta, or genital tract are associated with, and
are likely to directly cause, premature deliveries. Such infections, even if
they are ‘‘subclinical’’ (that is, they do not directly cause signs or
symptoms that the doctor or patient would notice) cause inflammation
in the affected tissues. Hence, it’s possible that particular proteins or
other molecules could provide a ‘‘signature’’ that would allow the
inflammation to be picked up at an early stage.
Why Was This Study Done? If inflammation could be picked up early,
this might help identify mothers at risk of having a preterm delivery, and
even to pinpoint cases of very severe inflammation where the baby is
more at risk of poor outcomes. The researchers involved in this study had
already done previous work looking at protein profiles in the amniotic
fluid (the liquid directly surrounding the developing fetus). They
identified a set of four protein ‘‘markers’’ that were closely associated
with inflammation in the amniotic fluid, and developed a score based on
those proteins, which they termed the ‘‘Mass Restricted’’ (MR) score. The
researchers showed that this score could accurately identify women at
risk of preterm delivery. However, before using the protein marker score
in clinical practice it is very important to really be sure it is a reliable
diagnostic test for preterm birth and adverse outcomes resulting from
preterm birth. Therefore the researchers wanted to find out whether MR
scores were associated with the outcome of pregnancy; the presence of
infection in the placenta, as detected through microscopic analysis of
tissue; and sepsis (severe infection) in the newborn baby.
What Did the Researchers Do and Find? The study was based on
findings from pregnant women presenting at the Yale-New Haven
Hospital with symptoms of premature labor, who were all followed up to
the point of delivery of the baby. In all cases the decisions about how to
manage the pregnancy (for example, whether to deliver the baby or
attempt to delay birth) were made by the woman and her physician, not
by any procedures laid out in the research study. A total of 169 women
were recruited into the study and had a sample of amniotic fluid taken as
part of their routine clinical management. The researchers then analyzed
this fluid to calculate the protein MR score, to look for evidence of
bacterial infection, and also carried out standard laboratory tests. After
childbirth the placenta was examined under the microscope to look for
any evidence of inflammation. Finally, all babies were checked for any
evidence of sepsis. The researchers found that, in line with findings from
their previous studies, women with a higher MR score gave birth sooner.
There also seemed to be a close agreement between the MR score and
evidence of inflammation in the placenta, once it was analyzed under the
microscope after birth. Furthermore, mothers with a high MR score were
more likely to give birth to babies with suspected or confirmed sepsis.
The researchers then compared the usefulness of the MR score against
other potential tests for inflammation. Of all the tests compared, the MR
score seemed to be the most accurate in predicting inflammation.
What Do These Findings Mean? This study showed that the MR score
was closely associated with a number of different indicators of poor
outcome in preterm birth. These outcomes included sooner deliveries,
sepsis in the baby, and inflammation in the placenta. In future, the MR
score may provide a useful test for recognizing women at risk of preterm
delivery and babies at risk of poor outcome. However, further evaluation
of the test will still need to be done before it could become a standard
procedure in the clinic.
Additional Information. Please access these Web sites via the online
version of this summary at http://dx.doi.org/10.1371/journal.pmed.
0040018.
  Information from the US National Institutes of Health on premature
babies
  The March of Dimes is a US charity that funds research into
prematurity
  Information from Wikipedia about proteomics the area of research
used to develop the protein score examined here (note: Wikipedia is
an online encyclopedia that anyone can edit)
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